Place an order request to the broker. The personal manager will contact you to confirm the order.

Order Summary

Asset: Select instrument
Quantity: -
Price per Unit: ? This price is indicative and shown for informational purposes only. The final execution price may change. -
Total Amount: -

Order Expiration

Order remains active until you cancel it or it gets filled

Order expires at the end of the selected day

Order Placed Successfully

Your order has been submitted! Our team will contact you shortly to confirm.

Order Type: -
Asset: -
Quantity: -
Total Amount: -
Manually record a past trade to keep your portfolio up to date. This helps track your P&L accurately.
Total Amount: $0.00

Trade Added Successfully

Trade recorded! Your portfolio data will be recalculated.

Type: -
Asset: -
Quantity: -
Price: -
Total: -

Chat Options

Web Search
Search the internet for recent information
Portfolio Context
Include your portfolio in the conversation
Market Data
Access real-time market information
Watchlist Context
Include your watchlist companies

Investment Managers Series Trus (IREX)

2026-10-01T00:17:17.301503+00:00

Key Updates

IREX declined a further 4.03% since the 28 September report, moving from $13.90 to the current $13.34. This extends an uninterrupted multi-session downtrend that has now persisted across five consecutive updates (from $17.83 → $15.95 → $15.46 → $13.90 → $13.34). The 1-day move of -2.56% confirms continued selling pressure into the close of the review period. Notably, no IREX-specific news was identified in this cycle; all eight news items concern unrelated issuers launching leveraged and inverse ETF products (Yorkville, BMO/REX, Leverage Shares, Tradr, Ninepoint, Jane Street), indicating the price action remains technically driven rather than catalyzed by fundamental developments specific to this fund.

Current Trend

IREX remains deeply negative on a YTD basis at -56.06%, with the 6-month performance of -10.71% indicating that the bulk of the decline occurred in earlier periods of the year, followed by a renewed acceleration over the past two weeks. The divergence between the 5-day return (-25.18%) and the 1-month return (+15.60%) highlights extreme intra-period volatility, consistent with a high-beta or leveraged-style instrument subject to sharp reversals. Immediate support sits at the current level of approximately $13.30–$13.34, representing a fresh multi-week low; resistance is located at the $15.46–$15.95 zone (late-September consolidation range) and further at $17.83 (prior swing high).

Investment Thesis

Given the absence of fund-specific fundamental news across multiple reporting cycles, the investment case for IREX continues to rest primarily on technical price behavior and the broader market environment for leveraged/volatility-linked products. The reviewed news flow confirms sustained industry-wide growth in leveraged and inverse ETF issuance (Yorkville MANGOS Plus, BMO/REX MicroSectors), alongside expanding dealer infrastructure supporting such products (Jane Street swaps entry). This signals elevated institutional risk appetite for volatility-linked instruments broadly, though no direct read-through to IREX's underlying strategy or holdings has been disclosed.

Thesis Status

The thesis remains unchanged from prior updates: bearish, with the continued absence of supportive fundamental catalysts reinforcing the negative technical trend. The persistence of the downtrend across five consecutive reporting periods, now totaling a decline from $17.83 to $13.34 (-25.2%) over a short span, confirms the deterioration flagged in the 25 and 28 September reports has not stabilized. No evidence currently supports a reversal thesis.

Key Drivers

No company-specific drivers were identified for IREX in this period. Market-wide drivers relevant to the leveraged/thematic ETF ecosystem include: continued proliferation of single-stock and sector-leveraged ETF launches (Leverage Shares Anthropic filings, Tradr Anthropic filings, Leverage Shares SK Hynix); and growing dealer participation in leveraged ETF swaps (Jane Street), which underscores a sector-wide trend toward higher-volatility, shorter-holding-period products rather than a specific driver of IREX price action.

Technical Analysis

IREX is trading at $13.34, down 2.56% on the day and testing fresh multi-week lows. The sharp divergence between the 5-day (-25.18%) and 1-month (+15.60%) returns indicates a mid-period rally that has since been fully reversed and extended into a new downleg, a pattern consistent with high-beta/volatility-reset dynamics referenced across the leveraged ETF products in the news flow. A break below the current $13.30 level would open room toward new YTD lows, while a recovery above $15.46 would be required to signal stabilization of the current downtrend.

Bull Case

  • One-month return remains positive (+15.60%), demonstrating capacity for sharp short-term rebounds typical of high-beta instruments.
  • Growing dealer participation in leveraged ETF swaps, including Jane Street's entry with $1.2bn notional in Q2, signals expanding liquidity and institutional infrastructure for volatility-linked products broadly (Bloomberg).
  • Continued issuance of new leveraged and inverse ETFs across sectors (communication services, consumer staples, semiconductors) reflects sustained investor demand for volatility-linked exposure, a supportive macro backdrop for the broader product ecosystem (PR Newswire).
  • Expansion of thematic energy and cross-border funds (e.g., Ninepoint's North American Energy Independence ETF) indicates continued investor appetite for diversified thematic strategies amid macro uncertainty (Reuters).
  • No negative company-specific news has emerged across multiple reporting periods, suggesting the decline is price/technical in nature rather than driven by a fundamental deterioration in the underlying strategy.

Bear Case

  • YTD performance of -56.06% reflects severe, sustained value erosion with no observed signs of reversal.
  • Price has fallen in five consecutive reporting cycles (from $17.83 to $13.34), an uninterrupted downtrend of approximately -25% over a short multi-week window.
  • No IREX-specific catalysts or fundamental news were identified in this cycle, leaving the position without a clear support narrative.
  • Elevated volatility profile (5d -25.18% vs 1m +15.60%) is consistent with daily-reset/compounding decay risks explicitly flagged by issuers of comparable leveraged products, which warn of substantial value loss potential in volatile markets (PR Newswire).
  • Technical breakdown below the $15.46–$15.95 support zone, with price now probing fresh lows, suggests continuation of downside momentum absent a clear reversal catalyst.

CapPilot is AI-powered and can make mistakes. Please double-check responses.

CapPilot leverages generative AI to distill market insights and analysis, as well as answer your questions in chat. While we work hard to ensure accuracy, AI-generated content may occasionally contain inaccuracies or outdated information.

We value your feedback — reporting errors helps us continuously improve.